"In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.

"In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
复制标题

“在他们的头脑中,他们总是感觉不到”:同龄人在转移耻辱作为阿片类药物使用障碍治疗保留的障碍方面的作用。

DOI:
10.1016/j.jsat.2022.108721
复制
发表时间:
2022-07
影响因子:
3.9
通讯作者:
Magidson, Jessica F.
Magidson, Jessica F.
中科院分区:
医学2区
文献类型:
--
作者:
Anvari, Morgan S.;Kleinman, Mary B.;Massey, Ebonie C.;Bradley, Valerie D.;Felton, Julia W.;Belcher, Annabelle M.;Magidson, Jessica F.

文献摘要

参考文献

被引文献

相似文献

对于文化上可接受的、可获得的阿片类药物使用障碍(OUD)治疗,存在着巨大的、全国性的需求。阿片类药物使用障碍(mud)被认为是治疗OUD的有效方法;然而,在全国范围内,mod项目的保留率仍然很低。阻碍mod留存的一个已知障碍是耻辱,特别是在少数民族社区。同伴康复专家(prs),在药物使用和康复方面有共同经验的人,可能特别适合支持吸毒成瘾治疗的患者,并且可能有能力在减少与吸毒成瘾相关的耻辱感障碍方面发挥关键作用。本研究采用定性方法征求关于接受美沙酮治疗(MT)的患者如何经历耻辱(即对物质使用[SU]和MT)的反馈。研究人员还收集了关于PRS角色如何减少耻辱感和提高护理留用率的信息,包括PRS角色转变耻辱感的障碍和促进因素。研究人员对巴尔的摩阿片类药物治疗项目和PRSs中接受MT的工作人员和患者进行了半结构化的定性访谈和焦点小组(N = 32)。参与者确定了内化以及制定和预期的MT和SU耻辱的经历,并将这些描述为治疗障碍。参与者还确定了通过PRS角色的独特方面,例如他们共享的生活经历,PRS可以改变接受MT患者的耻辱感相关障碍的机会。减少围绕SUD和MT的耻辱感对于改善mod结果至关重要,未来的研究可能会考虑PRS的作用如何支持这一努力。
A substantial, national need exists for culturally acceptable, accessible opioid use disorder (OUD) treatment. Medication for opioid use disorder (MOUD) is regarded as effective in treating OUD; however, retention in MOUD programs remains low nationally. One known barrier to MOUD retention is stigma, particularly within ethno-racial minority communities. Peer recovery specialists (PRSs), individuals with shared experience in substance use and recovery, may be particularly well suited to support patients in MOUD treatment, and may have capacity to play a key role in decreasing stigma-related barriers to MOUD retention. This study used qualitative methods to solicit feedback on how patients receiving methadone treatment (MT) experience stigma (i.e., toward substance use [SU] and MT). Study staff also gathered information regarding how a PRS role may reduce stigma and improve retention in care, including barriers and facilitators to the PRS role shifting stigma. Study staff conducted semi-structured qualitative interviews and focus groups (N = 32) with staff and patients receiving MT at an opioid treatment program as well as PRSs in Baltimore. Participants identified experiences of internalized, as well as enacted and anticipated, MT and SU stigma, and described these as barriers to treatment. Participants also identified opportunities for PRSs to shift stigma-related barriers for patients receiving MT through unique aspects of the PRS role, such as their shared lived experience. Reducing stigma surrounding SUD and MT is critical for improving MOUD outcomes, and future research may consider how the PRS role can support this effort.
DOI: 10.2105/ajph.2021.306431
发表时间: 2021-10-01
影响因子: 12.7
作者:
Larochelle, Marc R.;Slavova, Svetla;Samet, Jeffrey H.
通讯作者: Samet, Jeffrey H.
DOI: 10.1186/s13012-019-0853-y
发表时间: 2019-02-01
影响因子: 7.2
作者:
Gale, Randall C.;Wu, Justina;Midboe, Amanda M.
通讯作者: Midboe, Amanda M.
DOI: 10.1080/1556035x.2014.940769
发表时间: 2014-01-01
期刊: JOURNAL OF GROUPS IN ADDICTION & RECOVERY
影响因子: --
作者:
Haberle, Beverly J.;Conway, Stacey;Davidson, Larry
通讯作者: Davidson, Larry
DOI: 10.1177/0886109914531957
发表时间: 2015-02-01
期刊: AFFILIA-JOURNAL OF WOMEN AND SOCIAL WORK
影响因子: --
作者:
Jones, Lani V.;Hopson, Laura;James, Tana
通讯作者: James, Tana
DOI: 10.1371/journal.pone.0228755
发表时间: 2020-02-06
期刊: PLOS ONE
影响因子: 3.7
作者:
Pro, George;Zaller, Nick
通讯作者: Zaller, Nick